TUESDAY, June 15, 2021 (HealthDay News) — Researchers say an extra dose of two-dose COVID-19 vaccines may improve immune system protection for organ transplant patients, a group that’s so far responded poorly to two-dose vaccines. “Our findings suggest clinical trials are warranted to determine if transplant recipients should receive COVID-19Continue Reading
TUESDAY, June 8, 2021 (HealthDay News) — People who have Crohn’s disease often seek to ease their symptoms by changing what they eat, and new research suggests the Mediterranean diet may be their best bet. The study evaluated one of the commonly used diets for Crohn’s disease, known as theContinue Reading
TUESDAY, June 8, 2021 (HealthDay News) — New research suggests that many people who’ve undergone an organ transplant do not get an immune response from COVID-19 vaccines that’s strong enough to ward off a “breakthrough” infection. In a new review of 14 such cases, these breakthrough COVID-19 infections occurred inContinue Reading
THURSDAY, June 3, 2021 (HealthDay News) — Parkinson’s disease patients can get symptom relief with deep brain stimulation (DBS) therapy that lasts over the long term, a new study shows. Over 15 years, patients who received DBS, which requires surgical implantation, had significant improvement in motor symptoms and less needContinue Reading
THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading
WEDNESDAY, May 26, 2021 (HealthDay News) — A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “OurContinue Reading
FRIDAY, May 21, 2021 (HealthDay News) — A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition — eczema. In two phase 3 clinical trials, patients with moderate to severe eczema showed rapid and significant improvements after taking the drug, said researchers atContinue Reading
THURSDAY, May 20, 2021 (HealthDay News) — A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say. Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% takeContinue Reading
TUESDAY, May 18, 2021 (HealthDay News) — New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say. Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one inContinue Reading
WEDNESDAY, May 12, 2021 (HealthDay News) — Cora Oakley is a rough-and-tumble 4-year-old who loves gymnastics and outdoor activities, particularly if it involves bouncing on a trampoline. It’s hard to tell from looking at her that she was born without an immune system. Kids with this condition can acquire dangerous,Continue Reading
MONDAY, May 3, 2021 (HealthDay News) — Parkinson’s disease is widely seen as a movement disorder, but it can cause an array of symptoms, including hallucinations. Now a new study has shed light on what is happening in the brain during those disturbances. The study focused on Parkinson’s patients whoContinue Reading
FRIDAY, April 30, 2021 (HealthDay News) — COVID-19 infections may last longer in young people with weakened immune systems, and that extended period could lead to more mutations in SARS-CoV-2, according to the authors of a new case study. The study included two children and a young adult who hadContinue Reading
MONDAY, April 26, 2021 (HealthDay News) — A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials. There was a “night and day difference” in the results from bimekizumab compared against two establishedContinue Reading
WEDNESDAY, April 21, 2021 (HealthDay News) — People who suffer a traumatic brain injury (TBI) have a significantly higher risk for stroke for years afterward, U.K. researchers say. Previous studies have linked brain injury with a long-term risk of neurological diseases including dementia, Parkinson’s and epilepsy, and it’s been suggestedContinue Reading